Navigation Links
Callibra, Inc. dba Discharge 1-2-3™ is Named Top 75 Nominee for 10th Annual Chicago Innovation Awards
Date:10/5/2011

CHICAGO, Oct. 5, 2011 /PRNewswire/ -- Callibra, Inc. dba Discharge 1-2-3 of Schaumburg, IL, has been selected as one of the 75 nominees for the 2011 Chicago Innovation Awards.  The ten winners will be announced Tuesday, November 8th and celebrated at an event at Chicago's Harris Theater that evening.

The Chicago Innovation Awards, celebrating its 10th year, is the Chicago region's foremost recognition of the most innovative new products or services brought to market or to public service each year.  There were more than 400 nominees for the 2011 Chicago Innovation Awards, representing an increase of more than 60 percent over the past two years.

The innovation nominated by Callibra, Inc. is the Discharge 1-2-3 Composer™ which utilizes patent pending technology, and allows Emergency Physicians and staff fast point-and-click creation of custom patient discharge instructions in multiple languages.  The software will be available standalone and is currently available as part of Allscripts ED . “We are extremely pleased and honored by recognition for our work in information technology and clinical workflow automation that accelerates and enhances effective doctor – patient communication at the time of discharge,” said Dr. Christopher Galassi, CEO and Technical Director at Callibra, Inc. www.Discharge123.com

"The most important message of the Chicago Innovation Awards is one of confidence and courage," said Thomas D. Kuczmarski, co-founder with Chicago journalist Dan Miller of the awards.  "The economy is challenging but each nominee believes the simple truth that a powerful new product will find a rewarding market and has the courage to pursue their vision."

Each year ten winners are chosen from among the 75 finalists by a panel of judges reflecting a cross section of Chicago's business community.  In ad
'/>"/>

SOURCE Callibra, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Discharge of First U.S. DuraHeart(TM) Patient
2. Results and Additional Analyses From Study Show That Cortheras Relaxin for Acute Heart Failure is the Strongest Predictor of Improved Longer-Term Outcomes Following Hospital Discharge When Compared to Other Variables
3. Texas Childrens Hospital Discharges History-Making Teen Patient Again; This Time With a Transplanted Heart Replacing Mechanical Device
4. UKs 1st Total Artificial Heart Patient Discharged Home Using Freedom® Portable Driver
5. Aspirin Named 8th World Wonder by Majority of Americans
6. American Board of Internal Medicine President Named to Alzheimers Study Group
7. New York Infection Prevention Expert Named Recipient of Carole DeMille Award
8. Pharmaxis Establishes Named Patient Program for Bronchitol
9. University of Rochester Researcher Named Millennium Pharmaceuticals Career Development Scholar of The Leukemia & Lymphoma Society
10. Eularis Releases First-Ever Study on ROI of Pre-Launch Named Patient Programmes
11. Battelle Scientists Named on Patent for Making Oxygen From Light and Water
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... 17, 2014 /PRNewswire-iReach/ -- ChemImage announced today ... improvements in the development of imaging technology ... normal and diseased tissue that minimizes the ... procedures, lowers surgical costs and potentially enhances ... The clinical and scientific teams ...
(Date:9/17/2014)... 17, 2014 Prostate Oncology Specialists announces ... to educate men about new imaging technology destined ... prostate. Annually, a million men undergo random needle ... MRI (MP-MRI) of the prostate gland is non-invasive ... need to be fully informed of their alternatives. ...
(Date:9/17/2014)... , Sept. 17, 2014  Rebiotix Inc. announced this morning ... lead product candidate, RBX2660 (microbiota suspension) will be presented in ... conference in Philadelphia from October 8-12. ... during the poster session on Thursday, October 9, 2014: ... Infection: 60-Day Interim Analysis of the PUNCH-CD Phase 2 ...
Breaking Medicine Technology:Patient Outcomes Improve When Molecular Chemical Imaging Technology Is Used to Aid Robotic Surgical Procedures, According to New White Paper 2Prostate Cancer Awareness Month - Stop Random Biopsies 2Prostate Cancer Awareness Month - Stop Random Biopsies 3PUNCH CD Study Drug Targeting Recurrent C. difficile Infection to be Presented at IDWeek 2014 2PUNCH CD Study Drug Targeting Recurrent C. difficile Infection to be Presented at IDWeek 2014 3PUNCH CD Study Drug Targeting Recurrent C. difficile Infection to be Presented at IDWeek 2014 4
... ... ... ... ...
... , ... ... ... ...
Cached Medicine Technology:American Stroke Association Late-Breaking Science Report: New Drug as Effective as Warfarin in Preventing Strokes in Atrial Fibrillation Patients With Prior Stroke or TIA 2American Stroke Association Late-Breaking Science Report: New Drug as Effective as Warfarin in Preventing Strokes in Atrial Fibrillation Patients With Prior Stroke or TIA 3American Stroke Association Late-Breaking Science Report: New Drug as Effective as Warfarin in Preventing Strokes in Atrial Fibrillation Patients With Prior Stroke or TIA 4American Stroke Association Late-Breaking Science Report: New Drug as Effective as Warfarin in Preventing Strokes in Atrial Fibrillation Patients With Prior Stroke or TIA 5American Stroke Association Late-Breaking Science Report: New Drug as Effective as Warfarin in Preventing Strokes in Atrial Fibrillation Patients With Prior Stroke or TIA 6American Stroke Association Late-Breaking Science Report: New Drug as Effective as Warfarin in Preventing Strokes in Atrial Fibrillation Patients With Prior Stroke or TIA 7Dialysis Corporation of America Announces Fiscal Year 2009 Earnings Release Date 2Dialysis Corporation of America Announces Fiscal Year 2009 Earnings Release Date 3Dialysis Corporation of America Announces Fiscal Year 2009 Earnings Release Date 4
(Date:9/17/2014)... WEDNESDAY, Sept. 17, 2014 (HealthDay News) -- A blood ... could provide doctors with a better assessment of the ... If used routinely, this blood test could ... working and actually begins promoting tumor growth, the researchers ... given to patients with advanced prostate cancer and often ...
(Date:9/17/2014)... at The Scripps Research Institute (TSRI) have devised ... powerfully effective against vancomycin-resistant strains of MRSA and ... appears to have not one but two distinct ... cannot evolve resistance quickly. , "This is the ... be in clinical use a generation or maybe ...
(Date:9/17/2014)... 2014 Prevention is the best treatment ... scores of infants, children and teenagers in 12 states, ... medical director of Legacy ER & Urgent Care (LER) ... reported cases of EV-D68 so far in North Texas, ... change,” he said. “Implementing prevention strategies now may help ...
(Date:9/17/2014)... (PRWEB) September 18, 2014 Many countries ... influenza, instead of immunizations. The total number of poultry ... difficult to control, will result in huge losses. Therefore, ... avian influenza vaccines. , Avian influenza vaccines have been ... poultry farms in China began to use H5N1 avian ...
(Date:9/17/2014)... 2014 The Food and Drug Administration ... 2014, to consider: , 1. The ... 2. The potential for adverse cardiovascular ... TRT litigation ongoing, an informally-organized litigation group subcommittee prepared ... testosterone replacement therapy. Among others, ZKB attorney Michelle L. ...
Breaking Medicine News(10 mins):Health News:DNA Blood Test Might Identify Status of Prostate Cancer 2Health News:Scripps Research Institute chemists modify antibiotic to vanquish resistant bacteria 2Health News:Scripps Research Institute chemists modify antibiotic to vanquish resistant bacteria 3Health News:Legacy ER & Urgent Care Warns North Texans about Dangers of Enterovirus D68 2Health News:China Avian Influenza Vaccine Industry 2014-2018 Research Report Now Available at LifeScienceIndustryResearch.com 2Health News:China Avian Influenza Vaccine Industry 2014-2018 Research Report Now Available at LifeScienceIndustryResearch.com 3Health News:FDA Advisory Committee Holds Hearing on Testosterone Safety 2
... cannot control their conditions with medications need not worry now ... for their rescue. ,The new device ... the University of Rochester Medical Center as part of a ... significant reduction in the blood pressure in patients suffering from ...
... one in 10 U.S. adults suffer chronic pain that lasts a ... increased to a record average of just short of 80 years, ... Centers for Disease Control and Prevention. ,The CDC said, ... and nearly 75 for males. The gap in life expectancy between ...
... in birds with the avian virus that have infected human ... strains// of bird flu. ,The research has been ... which illustrates the genetic changes required for the H5N1 avian ... receptors on human cells. ,Yoshihiro Kawaoka, the senior ...
... genetic disorder, know that they shouldn't smoke or be ... developing emphysema at a young age. In addition, a ... (AT) deficiency could develop serious liver injuries due to ... ,A new research performed at Washington University School of ...
... helps them alleviate symptoms like forgetting, distracted, impulsive or ... Columbia University Medical Center// investigates whether these symptoms of ... smoke. ,If that is the case, ... to help people quit smoking – the patch with ...
... childcare worker should be trained in how to handle ... today.// ,'The AMA is calling on all State ... for people who work with children,' Dr Haikerwal said. ... for anaphylactic shock, including how to use auto-injecting devices ...
Cached Medicine News:Health News:A Novel Device System To Reduce Blood Pressure 2Health News:A Novel Device System To Reduce Blood Pressure 3Health News:Scinetists Alert to Onset of Pandemic through Bird flu Mutations to Humans 2Health News:Non-Steroidal Anti-Inflammatory Drugs Can Cause Liver Damages 2Health News:Non-Steroidal Anti-Inflammatory Drugs Can Cause Liver Damages 3Health News:A New Study To Examine ADHD's Role In Smoking 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: